Translate
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
SpanishLupin Pharmaceuticals
Fast Facts
Location: Somerset
Industry: Life Sciences
Country of Origin: India
Facility Type: Manufacturing Facility
Lupin Pharmaceuticals, Inc., headquartered in Somerset, New Jersey, has emerged as a significant player in the U.S. pharmaceutical market. The company, which is the third-largest by prescriptions in the country, has made substantial investments in research and development, totaling over $1 billion since 2016. This investment includes the strategic acquisition of its Somerset facility for $880 million, which has since undergone significant expansion. The company is committed to creating jobs and has already increased its workforce, with plans to add 50 more positions in the near future.
Lupin’s Somerset site has recently seen a major expansion, adding a new 100,000-square-foot facility that enhances its manufacturing capabilities and supports the growing demand for affordable medications. This expansion aligns with Lupin’s goal of leveraging its U.S. operations to meet ambitious targets within the generic pharmaceutical market. The new facility is expected to further bolster job creation and local economic development. As Lupin continues to expand its presence in New Jersey, it aims to solidify its role in the global pharmaceutical landscape while contributing to the local community and workforce.